Intrinsic Value

The intrinsic value of Anteris Technologies Ltd (AVR) under the Base Case is 0.39 AUD per share. Compared with the current market price of 9.11 AUD, the stock appears Overvalued by 96% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

AVR Intrinsic Value
AU$0.39
Overvaluation 96%
Intrinsic Value
Price AU$9.11

AVR is cheaper than usual. Still overvalued, but less so than on 86% of days in the past 5 years.

Monitor AVR
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value AU$0.31
Get notified when the price drops into your buy zone
Current Price AU$9.11
Intrinsic Value AU$0.39
Margin of Safety 20% AU$0.31
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to AVR

Fundamental Analysis

What Anteris Technologies Does

Health Care

Anteris Technologies Ltd is a medical device company focused on heart valve replacement. It develops the DurAVR transcatheter aortic valve system, which is designed to replace a diseased aortic valve through a minimally invasive procedure instead of open-heart surgery. The company also works with specialized heart tissue technology that is used in its valve products.

Headquarters
Australia AU
IPO date
Mar 24, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Anteris Technologies Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one AVR stock?

The intrinsic value for Anteris Technologies Ltd (AVR) under the Base Case is 0.39 AUD.

Is AVR stock undervalued or overvalued?

Compared with the current market price of 9.11 AUD, the stock appears Overvalued by 96% .

Back to Top